Richard Nolan Townsend
Chief Executive Officer at Lexeo Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Lexeo Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lexeo Therapeutics Inc. June 25, 202698.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Lexeo Therapeutics Inc. | Grant or award | +2,306 | $2.64 | $6,088 |
| Aug 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −3,345 | $4.95 | $16,558 |
| Jul 1, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −25,947 | $4.48 | $116,243 |
| Jun 29, 2026 | Lexeo Therapeutics Inc. | Grant or award | +67,000 | — | — |
| May 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −3,342 | $5.06 | $16,911 |
| Apr 6, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −55,000 | $5.69 | $312,950 |
| Mar 13, 2026 | Lexeo Therapeutics Inc. | Grant or award | +2,623 | $2.64 | $6,925 |
| Feb 18, 2026 | Lexeo Therapeutics Inc. | Open-market sale | −10,173 | $6.38 | $64,904 |
| Feb 4, 2026 | Lexeo Therapeutics Inc. | Grant or award | +161,665 | — | — |
| Nov 18, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −1,127 | $9.27 | $10,447 |
| Oct 17, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −12,985 | $8.94 | $116,086 |
| Oct 17, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −148 | $9.56 | $1,415 |
| Oct 15, 2025 | Lexeo Therapeutics Inc. | Grant or award | +33,000 | — | — |
| Sep 12, 2025 | Lexeo Therapeutics Inc. | Grant or award | +2,193 | $2.64 | $5,790 |
| Aug 18, 2025 | Lexeo Therapeutics Inc. | Open-market sale | −2,735 | $4.67 | $12,772 |
Questions about Richard Nolan Townsend
What boards is Richard Nolan Townsend on?
Richard Nolan Townsend sits on the board of Lexeo Therapeutics Inc.
What company is Richard Nolan Townsend the CEO of?
Richard Nolan Townsend has been Chief Executive Officer of Lexeo Therapeutics Inc. since November 2023.
How long has Richard Nolan Townsend served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.